Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
Blood (2016)
  • Guillermo Garcia-Manero, University of Texas MD Anderson Cancer Center
  • Megan Othus, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Cancer Institute
  • Jerald P. Radich, Fred Hutchinson Cancer Research Center
  • Min Fang, Fred Hutchinson Cancer Research Center
  • David A Rizzieri, Duke University
  • Guido Marcucci, Ohio State University
  • Stephen A. Strickland, Vanderbilt University Medical Center
  • Mark Litzow, Mayo Clinic
  • Mary Lynn Savoie, University of Calgary
  • Bruno C. Medeiros, Stanford University
  • Mikkael A. Sekeres, Cleveland Clinic
  • Tara L. Lin, University of Kansas
  • Geoffrey L. Uy, Washington University in St. Louis
  • Bayard L Powell, Wake Forest University
  • Jonathan E. Kolitz, Hofstra University
  • Richard A. Larson, University of Chicago
  • Richard M. Stone, Harvard University
  • David F. Claxton, Penn State Cancer Institute
  • James Essell, Jewish Hospital
  • Selina Luger, University of Pennsylvania
  • Sanjay R. Mohan, Vanderbilt University Medical Center
  • Anna Moseley, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Harry P. Erba, University of Alabama at Birmingham
Link
Disciplines
Publication Date
December 2, 2016
Citation Information
Guillermo Garcia-Manero, Megan Othus, John M. Pagel, Jerald P. Radich, et al.. "SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)" Blood Vol. 128 Iss. 22 (2016) p. 901 - 901
Available at: http://works.bepress.com/john-pagel/37/